|Mr. Tony Charara||Co-Founder & Exec. Director||80.97k||N/A||N/A|
|Mr. Cameron Jones C.A.||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Darryl Reed||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Michael Austin||Company Sec.||N/A||N/A||N/A|
Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987 and other dressing/matrices, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.
Tissue Repair Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.